Atlas FDA

TRUFILL N-BUTYL CYANOACRYLATE LIQUID EMBOLIC SYSTEM

FDA premarket approval P990040/S022 · decided 2016-06-03

Approval details

PMA number
P990040
Supplement
S022
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
TRUFILL N-BUTYL CYANOACRYLATE LIQUID EMBOLIC SYSTEM
Generic name
tissue adhesive for use in embolization of brain arteriovenous malformations
Applicant
Cerenovus, Inc.
Date received
2016-04-18
Decision date
2016-06-03
Days to decision
46 days
Decision code
APPR
Product code
KGG
Advisory committee
Neurology
Expedited review
No
Location
Miami, FL
Statement
Approval for modified acceptance criteria for n-BCA purity and a control limit for n-BCA dimers.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
CEREGLIDE 71 Catheter System; Cerenovus Aspiration Tubing Set (K251828)Cerenovus, Inc.2025-08-22
CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter; Cerenovus Aspiration Tubing Set (K241221)Cerenovus, Inc.2024-10-16
CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter (K241244)Cerenovus, Inc.2024-10-16
CEREGLIDE 92 Catheter System (K233982)Cerenovus, Inc.2024-05-09
Cerenovus Large Bore Catheter; Cerenovus Aspiration Tubing Set (K233988)Cerenovus, Inc.2024-01-17
CEREGLIDE 92 Intermediate Catheter (K230726)Cerenovus, Inc.2023-11-29
CEREGLIDE 71 Intermediate Catheter; Cerenovus Aspiration Tubing Set (K221934)Cerenovus, Inc.2023-03-09
CEREGLIDE 71 Intermediate Catheter (K221930)Cerenovus, Inc.2023-03-09